Exact Sciences wins FDA approval for non-invasive colorectal cancer test
Big news came late Monday for Exact Sciences Corp.: The U.S. Food and Drug Administration has approved Cologuard, the Madison company’s non-invasive test to screen for colorectal cancer. (STATE JOURNAL, 8/12)
To access this content, you must purchase a Premium membership, or log in if you are a member.
